2025年4月4日 周五
Home > Archive>Volume 31, Issue 11, 2023 >929-937
PDF HTML XML Export Cite reminder
Xeroderma pigmentosum group D gene inhibits the proliferation of human umbilical vein smooth muscle cell induced by ox-LDLvia down-regulating mTOR/LOX-1 pathway
CSTR:
[cstr]
Author:
Affiliation:

Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang Universty, Nanchang, Jiangxi 330006, China)

Clc Number:

R5; R363

  • Article
    • | |
  • Metrics
    • |
  • Reference [36]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Aim To investigate the mechanism and signal pathways of xeroderma pigmentosum group D(XPD) gene on the proliferation of human umbilical vein smooth muscle cell (HUVSMC) induced by ox-LDL. Methods HUVSMCs were transfected with the plasmids of pEGFP-N2/XPD using Lipofectamine 2000, and subsequently silent mTOR gene. MTT and EdU assay was used to detect the cell proliferation. Flow cytometry was used to examine the cell apoptosis. The expression of XPD, lectin-like oxidized low-density lipoprotein receptor 1(LOX-1), mTOR, phospho-mTOR, Bcl-2 and Bax was measured by Western blot. Results The expression of XPD and Bax protein was down-regulated in ox-LDL group (P＜0.05), while the expression of LOX-1, mTOR, Bcl-2 protein and the ratio of Bcl-2/Bax was significantly up-regulated (P＜0.05), compared with control group. Cell proliferation of ox-LDL group increased obviously (P＜0.05). After transfected with the pEGFP-N2/XPD plasmid, the expression of Bax was significantly up-regulated, while the expression of LOX-1, mTOR, Bcl-2 and the ratio of Bcl-2/Bax were significantly down-regulated (P＜0.05). Flow cytometry showed that overexpression of XPD increased the apoptosis rate of HUVSMC (P＜0.05). MTT and BdU showed that cell proliferation of pEGFP-N2/XPD group reduced compared with control group (P＜0.05). Compared with control group, the expression of LOX-1 was significantly down-regulated in siRNA mTOR group (P＜0.05). Conclusion XPD can inhibit HUVSMC proliferation and promote its apoptosis, and reduce the effect of ox-LDL promoting proliferation of HUVSMC via the mTOR/LOX-1 pathway. XPD may be the target of treatment of atherosclerosis.

    Reference
    [1] 罗宇霖, 袁渊, 罗茂.细胞外囊泡微小RNA在动脉粥样硬化中的作用研究进展.中国动脉硬化杂志, 3,1(2):157-4,0.LUO Y L, YUAN Y, LUO M.Research progress on the role of extracellular vesicle microRNA in atherosclerosis.Chin J Arterioscler, 3,1(2):157-4,0.
    [2] KATTOOR A J, KANURI S H, MEHTA J L.Role of ox-LDL and LOX-1 in atherogenesis.Curr Med Chem, 9,6(9):1693-1700.
    [3] KHATANA C, SAINI N K, CHAKRABARTI S, et al.Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis.Oxid Med Cell Longev, 0,0:5245308.
    [4] LOW G K M, TING A P L, FOK E D Z, et al.Role of xeroderma pigmentosum D (XPD) protein in genome maintenance in human cells under oxidative stress.Mutat Res Genet Toxicol Environ Mutagen, 2,6-877:503444.
    [5] LEHMANN A R.The xeroderma pigmentosum group D (XPD) gene:one gene, two functions, three diseases.Genes Dev, 1,5(1):15-23.
    [6] LAWANIA S, SINGH N, BEHERA D, et al.Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy.Future Oncol, 7,3(29):2645-2665.
    [7] FREDERICK G D, AMIRKHAN R H, SCHULTZ R A, et al.Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.Hum Mol Genet, 4,3(10):1783-1788.
    [8] DING H, WEN Z L, SUN G F.Silencing of xeroderma pigmentosum group D gene promotes hepatoma cell growth by reducing P53 expression.Med Sci Monit, 8,4:8015-8021.
    [9] MA J M, SHAO X L, GENG F, et al.ERCC2/XPD deficiency results in failure of digestive organ growth in zebrafish with elevated nucleolar stress.iScience, 2,5(9):104957.
    [10] LUO Y D, FANG L, YU H Q, et al.p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.J Hepatol, 1,4(1):96-108.
    [11] KON N, OU Y, WANG S J, et al.mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression.Genes Dev, 1,5(1/2):59-64.
    [12] SHORNING B Y, DASS M S, SMALLEY M J, et al.The PI3K-Akt-mTOR pathway and prostate cancer:at the crossroads of AR, MAPK, and WNT signaling.Int J Mol Sci, 0,1(12):4507.
    [13] RINCK-JUNIOR J A, TORRICELLI C, GOMEZ G V B, et al.Influence of functional variants Asp312Asn and Lys751Gln of xeroderma pigmentosum group D (XPD) and glutathione S-transferase Mu 1 (GSTM1) and Theta 1 (GSTT1) genes on cutaneous melanoma susceptibility and prognosis.Exp Dermatol, 9,8(5):631-635.
    [14] HE Y, TAO W Q, SHANG C, et al.Xeroderma pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway.Int J Exp Pathol, 1,2(3):157-162.
    [15] 夏子荣, 李青, 夏珍, 等.剪切修复基因XPD抑制Ox-LDL诱导人脐 动脉平滑肌细胞的增殖.中国病理生理杂志, 7,3(12):2238-2244.XIA Z R, LI Q, XIA Z, et al.Effect of xeroderma pigmentosum group D gene on proliferation of human umbilical arterial smooth muscle cells induced by ox-LDL.Chin J Pathophysiol, 7,3(12):2238-2244.
    [16] ZHANG H, WANG Y, DING H.COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.Clin Transl Oncol, 1,3(10):2078-2089.
    [17] LEE S B, LEE S, PARK J Y, et al.Induction of p53-dependent apoptosis by prostaglandin a2.Biomolecules, 0,0(3):492.
    [18] ZHANG G P, GUAN Y Y, ZHAO Y J, et al.ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.Chem Biol Interact, 7,3:55-65.
    [19] LIBBY P.The changing landscape of atherosclerosis.Nature, 1,2(7855):524-533.
    [20] BIROS E, REZNIK J E, MORAN C S.Role of inflammatory cytokines in genesis and treatment of atherosclerosis.Trends Cardiovasc Med, 2,2(3):138-142.
    [21] GROOTAERT M O J, MOULIS M, ROTH L, et al.Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis.Cardiovasc Res, 8,4(4):622-634.
    [22] ZHANG L, CHENG H L, YUE Y X, et al.H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL-stimulated vascular smooth muscle cells.J Biomed Sci, 8,5(1):11.
    [23] ZHAO S, ZHANG Y C, LU X Q, et al.CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2/Bax pathway.Int J Biol Sci, 1,7(13):3608-3621.
    [24] KATTOOR A J, GOEL A, MEHTA J L.LOX-1:regulation, signaling and its role in atherosclerosis.Antioxidants (Basel), 9,8(7):218.
    [25] BALZAN S, LUBRANO V.LOX-1 receptor:a potential link in atherosclerosis and cancer.Life Sci, 8,8:79-86.
    [26] OU H C, CHOU W C, HUNG C H, et al.Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.Environ Toxicol, 9,4(7):825-835.
    [27] LI H L, ZHUANG W W, XIONG T Q, et al.Nrf2 deficiency attenuates atherosclerosis by reducing LOX-1-mediated proliferation and migration of vascular smooth muscle cells.Atherosclerosis, 2,7:1-16.
    [28] WANG Z W, CHEN J, ZENG Z L, et al.The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing ox-LDL from the circulation.Mol Med, 2,8(1):26.
    [29] MOSSMANN D, PARK S, HALL M N.mTOR signalling and cellular metabolism are mutual determinants in cancer.Nat Rev Cancer, 8,8(12):744-757.
    [30] SAXTON R A, SABATINI D M.mTOR signaling in growth, metabolism, and disease.Cell, 7,9(2):361-371.
    [31] ZHAO L, DING T, CYRUS T, et al.Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.Br J Pharmacol, 9,6(5):774-785.
    [32] CHEN W Q, ZHONG L, ZHANG L, et al.Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.Br J Pharmacol, 9,6(6):941-951.
    [33] 李玉婷, 冯森玲, 林彩燕, 等.雷帕霉素脂质体对 ox-LDL诱导血管平滑肌细胞迁移的抑制作用.中国动脉硬化杂志, 3,1(7):581-587.LI Y T, FENG S L, LIN C Y, et al.inhibitory effect of rapamycin liposomes on ox-LDL induced vascular smooth muscle cell migration.Chin J Arterioscler, 3,1(7):581-587.
    [34] DOU Y, GUO J W, CHEN Y, et al.Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice.J Control Release, 6,5:48-62.
    [35] ZHOU Y D, CAO X Q, LIU Z H, et al.Rapamycin inhibits oxidized low density lipoprotein uptake in human umbilical vein endothelial cells via mTOR/NF-κB/LOX-1 pathway.PLoS One, 6,1(1):e0146777.
    [36] DING Z F, LIU S J, WANG X W, et al.Lectin-like oxidized low-density lipoprotein receptor-1 regulates autophagy and Toll-like receptor 4 in the brain of hypertensive mice.J Hypertens, 5,3(3):525-533.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

YU Weiying, XIA Zirong, LI Qin, XIA Zhen, LI Juxiang. Xeroderma pigmentosum group D gene inhibits the proliferation of human umbilical vein smooth muscle cell induced by ox-LDLvia down-regulating mTOR/LOX-1 pathway[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(11):929-937.

Copy
Share
Article Metrics
  • Abstract:419
  • PDF: 750
  • HTML: 0
  • Cited by: 0
History
  • Received:April 03,2023
  • Revised:July 02,2023
  • Online: December 05,2023
Article QR Code

You are the 27156 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025